-
Product Insights
NewNet Present Value Model: Kyowa Kirin Co Ltd’s Rocatinlimab
Empower your strategies with our Net Present Value Model: Kyowa Kirin Co Ltd's Rocatinlimab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Innovation Ranking
Innovation Ranking – Kirin Holdings Co Ltd
Kirin Holdings Co Ltd (Kirin) manufactures and markets alcoholic and non-alcoholic beverages and pharmaceuticals products. Its major products include beer, wine, hopposhu, new genre, sprits, chu-hi, whiskey, seltzer, kombucha, black tea, coffee, tea, fruit juice, dairy products, carbonated beverages, health/sports beverages, ionized natural water, and pharmaceutical drugs. The company markets its products under Kirin Hyoketsu, Honkirin, James Squire, iMUSE, Cognizin, Kirin Gogo-no-Kocha, Kirin Nama-cha, XXXX, Kirin Ichiban, Berri, Baden, San Miguel Pale Pilsen, Spring Valley, Kirin Nodogoshi Nama, Kirin FREE,...
-
Innovation Ranking
Innovation Ranking – Kyowa Kirin Co Ltd
Kyowa Kirin Co Ltd (Kyowa Kirin), a subsidiary of Kirin Holdings Co Ltd, is a biotechnology company focused on research and development. It is involved in the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, angina pectoris, hypertension,...
-
Product Insights
NewNet Present Value Model: Ionis Pharmaceuticals Inc’s Evazarsen Sodium
Empower your strategies with our Net Present Value Model: Ionis Pharmaceuticals Inc's Evazarsen Sodium report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewMycosis Fungoides Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Mycosis Fungoides Clinical Trial Report Overview A total of 328 mycosis fungoides clinical trials were conducted as of April 2024. The mycosis fungoides clinical trial report provides a comprehensive understanding of the mycosis fungoides clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       North America ·       ...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tivozanib in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tivozanib in Diabetic Macular Edema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tivozanib in Diabetic Macular Edema Drug Details: Tivozanib is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tivozanib in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tivozanib in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tivozanib in Wet (Neovascular / Exudative) Macular...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rocatinlimab in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rocatinlimab in Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rocatinlimab in Asthma Drug Details: Rocatinlimab is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KK-2269 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KK-2269 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KK-2269 in Solid Tumor Drug Details: KK-2269 is under development for...
-
Product Insights
NewQuarterly Vodka pricing trends in Brazil
Empower your strategies with our Quarterly Vodka pricing trends in Brazil report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....